Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma

Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma

Background and aims: Radiofrequency ablation (RFA) often results in incomplete ablation for medium-to-large and irregular tumors. To solve this clinical problem, we proposed a new treatment strategy of OK-432 in combination with an anti-programmed cell death protein 1 (αPD-1) antibody for residual t...

Full description

Bibliographic Details
Main Authors:	Tao Sun, Bo Sun, Yanyan Cao, Jiayun Liu, Juan Chen, Bin Liang, Chuansheng Zheng, Xuefeng Kan
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Radiofrequency ablation Hepatocellular carcinoma OK-432 Programmed death-1
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223011423

Similar Items

Percutaneous sclerotherapy with OK-432 for lymphocele after pelvic or para-aortic lymphadenectomy: preliminary results
by: Eiji Kashiwagi, et al.
Published: (2022-10-01)

OK-432 Treatment of Ranula Intruding into the Cervical Region
by: Nobuo Ohta, et al.
Published: (2022-03-01)

Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis
by: Jiali Sun, et al.
Published: (2023-07-01)

OK-432 (Sapylin) Reduces Seroma Formation After Axillary Lymphadenectomy in Breast Cancer
by: Deguang Kong, et al.
Published: (2017-01-01)

The Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-γ Production by OK-432 via the CD40/CD40 Ligand Pathway
by: Go Ohe, et al.
Published: (2021-06-01)

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma
by: Takahiro Osuga, et al.
Published: (2024-03-01)

Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
by: Dong Ik Cha, et al.
Published: (2023-10-01)

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
by: Hyo-Cheol Kim
Published: (2023-10-01)

An image fusion system for estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma
by: Toshikuni Nobuyuki, et al.
Published: (2017-07-01)

Comparing the Safety and Efficacy of Microwave Ablation Using Thermosphere<sup>TM</sup> Technology versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
by: Hidekatsu Kuroda, et al.
Published: (2021-03-01)

Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01)

Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma
by: Takuya Wada, et al.
Published: (2023-01-01)

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
by: Ming Liu, et al.
Published: (2023-03-01)

A Case of needle-tract implantation of hepatocellular carcinoma in the ovary after radiofrequency ablation
by: Seong Woon Yoon, et al.
Published: (2017-12-01)

Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis
by: Lingkai Zhang, et al.
Published: (2023-01-01)

Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review
by: Peiman Habibollahi, et al.
Published: (2020-12-01)

Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events
by: Min Geun Jo, et al.
Published: (2023-01-01)

Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis
by: Peng Guo, et al.
Published: (2024-04-01)

Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Jeong-Ju Yoo, et al.
Published: (2024-01-01)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
by: Jinbin Chen, et al.
Published: (2018-10-01)

Machine Learning–Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation
by: Masaya Sato, et al.
Published: (2022-01-01)

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma
by: Po-Yueh Chen, et al.
Published: (2021-10-01)

Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
by: Yanyan Cao, et al.
Published: (2023-11-01)

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Byung-Yoon Yun, et al.
Published: (2020-09-01)

Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver
by: MeeYoung Kang, et al.
Published: (2023-06-01)

Limited benefits from no-touch radiofrequency ablation in small hepatocellular carcinoma: Systematic review with meta-analysis
by: Lingkai Zhang, et al.
Published: (2023-12-01)

Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation
by: Yuan-Hung Kuo, et al.
Published: (2023-06-01)

A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma
by: Soon Kyu Lee, et al.
Published: (2022-01-01)

Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
by: Yanyan Cao, et al.
Published: (2023-12-01)

Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2024-01-01)

Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
by: Dong Ik Cha, et al.
Published: (2023-01-01)

Radiofrequency Ablation for Adenomyosis
by: Ioannis Dedes, et al.
Published: (2023-04-01)

Comparison of laparoscopic hepatectomy and percutaneous radiofrequency ablation for the treatment of small hepatocellular carcinoma: a meta-analysis
by: Fei Liu, et al.
Published: (2024-03-01)

Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation
by: Yeshong Park, et al.
Published: (2023-07-01)

Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
by: Hideko Ohama, et al.
Published: (2022-12-01)

Radiofrequency ablation induces tumor cell dissemination in a mouse model of hepatocellular carcinoma
by: Bowen Zhuang, et al.
Published: (2023-11-01)

Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa<sup>®</sup> and VIVA<sup>®</sup> Systems
by: Hiroaki Takaya, et al.
Published: (2022-01-01)

Transcervical radiofrequency ablation of focal adenomyosis: pilot results
by: Elvin Piriyev, et al.
Published: (2023-12-01)

Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
by: Yuanfeng Meng, et al.
Published: (2023-12-01)

Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience
by: Haiyi Long, et al.
Published: (2023-12-01)